AW
NVCR icon

Avion Wealth’s NovoCure NVCR Stock Holding History

Avion Wealth’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38
Closed – – 1478
2025
Q3 		$0 Hold
38
– – ﹤0.01% 1435
2025
Q2 		$0 Hold
38
– – ﹤0.01% 1470
2025
Q1 		$1K Hold
38
– – ﹤0.01% 895
2024
Q4 		$1K Hold
38
– – ﹤0.01% 892
2024
Q3 		$0 Sell
38
-44
-54% -$798 ﹤0.01% 1236
2024
Q2 		$1K Buy
82
+44
+116% +$774 ﹤0.01% 777
2024
Q1 		$1K Hold
38
– – ﹤0.01% 1023
2023
Q4 		$1K Buy
+38
New +$509 ﹤0.01% 902

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Avion Wealth's NVCR Position: Q4 2025 in Review

Avion Wealth sold out of NovoCure (NVCR) in Q4 2025, closing a stake of 38 shares.

Avion Wealth first reported a position in NVCR in Q4 2023 and held it in 8 quarters. The position peaked at $1K in Q1 2025. 238 funds tracked by Wall St. Rank hold NVCR as of Q4 2025.

  • Avion Wealth reported no remaining NovoCure position as of Q4 2025 after selling out during the quarter.
  • Avion Wealth sold 38 NovoCure shares in Q4 2025.
  • Avion Wealth first reported a position in NovoCure in Q4 2023 and held it in 8 quarters.
  • Avion Wealth's NovoCure position peaked at $1K in Q1 2025.
  • 238 funds tracked by Wall St. Rank held NovoCure as of Q4 2025.

Based on Avion Wealth's 13F filing for Q4 2025, filed 23 Jan 2026.